| abstract |
Provided herein are crystalline and salt forms of methyl N -{(1R)-2-[(2S)-2-{5-[4-(6- {2- [(2S)- 1 - {(2S)-2- [(methoxycarbonyl)amino] -3 -methylbutanoyl} pyrro lidin-2-yl]-3 H - benzimidazol-5-y1}thieno[3,2- b ]thiophen-3-y1)phenyl]-1 H -imidazol-2-yl}pyrrolidin-1-y1]-2- oxo-1-phenylethyl} carbamate, a Flaviviridae, including hepatitis C, virus inhibitor, pharmaceutical compositions comprising the compound, and processes of preparation thereof. Also provided are methods of its use for the treatment of a Flaviviridae, including HCV, infection in a subject in need thereof. |